Methamphetamine downregulates peroxiredoxins in rat pheochromocytoma cells

Biochemical and Biophysical Research Communications

Volumn 354, Issue 1, 2007, Pages 96-101

  Chen, Han Min ^a   Lee, Yi Chao ^b   Huang, Chuen Lin ^c   Liu, Hui Kang ^d   Liao, Wei Chen ^e   Lai, Wen Lin ^e   Lin, Yen Ru ^d   Huang, Nai Kuei ^d  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b Institute of Signal Transduction   (Taiwan)

^c CARDINAL TIEN HOSPITAL   (Taiwan)

^d National Research Institute of Chinese Medicine   (Taiwan)

^e NATIONAL TAITUNG UNIVERSITY   (Taiwan)

Author keywords

Methamphetamine; Peroxiredoxin; Thioredoxin; Thioredoxin reductase

Indexed keywords

METHAMPHETAMINE; PEROXIREDOXIN; RADICAL; THIOREDOXIN; THIOREDOXIN REDUCTASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME MODIFICATION; ENZYME REGULATION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ANIMALS; APOPTOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; METHAMPHETAMINE; PC12 CELLS; PEROXIDASES; PEROXIREDOXINS; RATS; SIGNAL TRANSDUCTION; THIOREDOXINS;

ANIMALIA; RATTUS;

EID: 33846324299     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.138     Document Type: Article

References (43)

1. Wagner G.C., Seiden L.S., and Schuster C.R. Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs. Drug Alcohol Depend. 4 (1979) 435-438
2. Wagner G.C., Ricaurte G.A., Johanson C.E., Schuster C.R., and Seiden L.S. Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate. Neurology 30 (1980) 547-550
3. Koda L.Y., and Gibb J.W. Adrenal and striatal tyrosine hydroxylase activity after methamphetamine. J. Pharmacol. Exp. Ther. 185 (1973) 42-48
4. Ellison G., Eison M.S., Huberman H.S., and Daniel F. Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 201 (1978) 276-278
5. Cadet J.L., Ordonez S.V., and Ordonez J.V. Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2. Synapse 25 (1997) 176-184
6. Stumm G., Schlegel J., Schafer T., Wurz C., Mennel H.D., Krieg J.C., and Vedder H. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J. 13 (1999) 1065-1072
7. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Brain Res. Rev. 36 (2001) 1-22
8. Brown J.M., and Yamamoto B.K. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol. Ther. 99 (2003) 45-53
9. Funada M., Zhou X., Satoh M., and Wada K. Profiling of methamphetamine-induced modifications of gene expression patterns in the mouse brain. Ann. N. Y. Acad. Sci. 1025 (2004) 76-83
10. Iwazaki T., McGregor I.S., and Matsumoto I. Protein expression profile in the striatum of acute methamphetamine-treated rats. Brain Res. 1097 (2006) 19-25
11. Hofmann B., Hecht H.J., and Flohe L. Peroxiredoxins. Biol. Chem. 383 (2002) 347-364
12. Rhee S.G., Chae H.Z., and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38 (2005) 1543-1552
13. Krapfenbauer K., Engidawork E., Cairns N., Fountoulakis M., and Lubec G. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res. 967 (2003) 152-160
14. Schafer F.Q., and Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30 (2001) 1191-1212
15. Arner E.S., and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267 (2000) 6102-6109
16. Holmgren A. Thioredoxin. Annu. Rev. Biochem. 54 (1985) 237-271
17. Nordberg J., and Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 31 (2001) 1287-1312
18. Bersani N.A., Merwin J.R., Lopez N.I., Pearson G.D., and Merrill G.F. Protein electrophoretic mobility shift assay to monitor redox state of thioredoxin in cells. Methods Enzymol. 347 (2002) 317-326
19. Kalasinsky K.S., Bosy T.Z., Schmunk G.A., Reiber G., Anthony R.M., Furukawa Y., Guttman M., and Kish S.J. Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users. Forensic. Sci. Int. 116 (2001) 163-169
20. Jayanthi S., Deng X., Noailles P.A., Ladenheim B., and Cadet J.L. Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J. 18 (2004) 238-251
21. Immenschuh S., and Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid. Redox Signal. 7 (2005) 768-777
22. Berggren M.I., Husbeck B., Samulitis B., Baker A.F., Gallegos A., and Powis G. Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin. Arch. Biochem. Biophys. 392 (2001) 103-109
23. Nonn L., Berggren M., and Powis G. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol. Cancer Res. 1 (2003) 682-689
24. Yuan J., Murrell G.A., Trickett A., Landtmeters M., Knoops B., and Wang M.X. Overexpression of antioxidant enzyme peroxiredoxin 5 protects human tendon cells against apoptosis and loss of cellular function during oxidative stress. Biochim. Biophys. Acta 1693 (2004) 37-45
25. Wong C.M., Chun A.C., Kok K.H., Zhou Y., Fung P.C., Kung H.F., Jeang K.T., and Jin D.Y. Characterization of human and mouse peroxiredoxin IV: evidence for inhibition by Prx-IV of epidermal growth factor- and p53-induced reactive oxygen species. Antioxid. Redox Signal. 2 (2000) 507-518
26. Nagy N., Malik G., Fisher A.B., and Das D.K. Targeted Disruption of Peroxiredoxin 6 Gene Renders the Heart Vulnerable to Ischemia Reperfusion Injury. Am. J. Physiol. Heart Circ. Physiol. (2006)
27. Seo M.S., Kim J.K., Lim Y., Kang S.W., Cho Y.J., Lee W.K., Kim H.J., Cho K.K., Lee K.H., and Rhee S.G. Rapid degradation of PrxI and PrxII induced by silica in Rat2 cells. Biochem. Biophys. Res. Commun. 265 (1999) 541-544
28. Fornai F., Lenzi P., Gesi M., Soldani P., Ferrucci M., Lazzeri G., Capobianco L., Battaglia G., De Blasi A., Nicoletti F., and Paparelli A. Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells. J. Neurochem. 88 (2004) 114-123
29. Fornai F., Lenzi P., Gesi M., Ferrucci M., Lazzeri G., Capobianco L., de Blasi A., Battaglia G., Nicoletti F., Ruggieri S., and Paparelli A. Similarities between methamphetamine toxicity and proteasome inhibition. Ann. N. Y. Acad. Sci. 1025 (2004) 162-170
30. Jurado J., Prieto-Alamo M.J., Madrid-Risquez J., and Pueyo C. Absolute gene expression patterns of thioredoxin and glutaredoxin redox systems in mouse. J. Biol. Chem. 278 (2003) 45546-45554
31. Das K.C., Guo X.L., and White C.W. Induction of thioredoxin and thioredoxin reductase gene expression in lungs of newborn primates by oxygen. Am. J. Physiol. 276 (1999) L530-L539
32. Mirecki A., Fitzmaurice P., Ang L., Kalasinsky K.S., Peretti F.J., Aiken S.S., Wickham D.J., Sherwin A., Nobrega J.N., Forman H.J., and Kish S.J. Brain antioxidant systems in human methamphetamine users. J. Neurochem. 89 (2004) 1396-1408
33. Moszczynska A., Turenne S., and Kish S.J. Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine. Neurosci. Lett. 255 (1998) 49-52
34. Jayanthi S., Ladenheim B., and Cadet J.L. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann. N. Y. Acad. Sci. 844 (1998) 92-102
35. Hom D.G., Jiang D., Hong E.J., Mo J.Q., and Andersen J.K. Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity. Brain Res. Mol. Brain. Res. 46 (1997) 154-160
36. Casagrande S., Bonetto V., Fratelli M., Gianazza E., Eberini I., Massignan T., Salmona M., Chang G., Holmgren A., and Ghezzi P. Glutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systems. Proc. Natl. Acad. Sci. USA 99 (2002) 9745-9749
37. Lau J.W., Senok S., and Stadlin A. Methamphetamine-induced oxidative stress in cultured mouse astrocytes. Ann. N. Y. Acad. Sci. 914 (2000) 146-156
38. Kang S.W., Rhee S.G., Chang T.S., Jeong W., and Choi M.H. 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends Mol. Med. 11 (2005) 571-578
39. Powis G., and Montfort W.R. Properties and biological activities of thioredoxins. Annu. Rev. Biophys. Biomol. Struct. 30 (2001) 421-455
40. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., and Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275 (1997) 90-94
41. Jayanthi S., McCoy M.T., Ladenheim B., and Cadet J.L. Methamphetamine causes coordinate regulation of Src, Cas, Crk, and the Jun N-terminal kinase-Jun pathway. Mol. Pharmacol. 61 (2002) 1124-1131
42. Deng X., Jayanthi S., Ladenheim B., Krasnova I.N., and Cadet J.L. Mice with partial deficiency of c-Jun show attenuation of methamphetamine-induced neuronal apoptosis. Mol. Pharmacol. 62 (2002) 993-1000
43. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17 (1998) 2596-2606